Malaysian Genomics Resource Centre Bhd (XKLS:0155) Equity-to-Asset : 0.84 (As of Sep. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Malaysian Genomics Resource Centre Bhd's Total Stockholders Equity for the quarter that ended in Sep. 2023 was RM28.17 Mil. Malaysian Genomics Resource Centre Bhd's Total Assets for the quarter that ended in Sep. 2023 was RM33.72 Mil. Therefore, Malaysian Genomics Resource Centre Bhd's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.84.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's Equity-to-Asset or its related term are showing as below:

XKLS:0155' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.42 Med: 0.85 Max: 0.96
Current: 0.84

During the past 13 years, the highest Equity to Asset Ratio of Malaysian Genomics Resource Centre Bhd was 0.96. The lowest was 0.42. And the median was 0.85.

XKLS:0155's Equity-to-Asset is ranked better than
88.51% of 235 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs XKLS:0155: 0.84

Malaysian Genomics Resource Centre Bhd Equity-to-Asset Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Equity-to-Asset Chart

Malaysian Genomics Resource Centre Bhd Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Equity-to-Asset

Get a 7-Day Free Trial

0.64

0.48

0.43

0.79

Malaysian Genomics Resource Centre Bhd Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23
Equity-to-Asset	Get a 7-Day Free Trial															0.88	0.89	0.90	0.90	0.84

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Equity-to-Asset

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Malaysian Genomics Resource Centre Bhd's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Equity-to-Asset falls into.

Malaysian Genomics Resource Centre Bhd Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Malaysian Genomics Resource Centre Bhd's Equity to Asset Ratio for the fiscal year that ended in Jun. 2021 is calculated as

Equity to Asset (A: Jun. 2021 )	=	Total Stockholders Equity	/	Total Assets
	=	17.93	/	22.783
	=	0.79

Malaysian Genomics Resource Centre Bhd's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	28.169	/	33.716
	=	0.84

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Malaysian Genomics Resource Centre Bhd Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810

Website

http://www.mgrc.com.my

Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines